Curis | CRIS - Net Income


Curis reported $-11.8M in Net Income for its fiscal quarter ending in June of 2024.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Amgen USD 1.33B 1.88B Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
CSL USD 401M 96.5M Dec/2025
Curis USD -11.8M 80K Jun/2024
Eli Lilly USD 6.64B 1.05B Dec/2025
Exelixis USD 193.58M 8.73M Sep/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Takeda JPY 103.64B 115.44B Dec/2025
TG Therapeutics USD 23.04M 367.86M Dec/2025
Verastem USD -8.26M 25.61M Jun/2024
Xoma USD -17.24M 33.23M Sep/2024